Dear There,

Effective May 31, 2023, the Food and Drug Administration (FDA) approved ABRYSVO™ (Respiratory Syncytial Virus Vaccine).

Please click the link below for important drug and coding information for ABRYSVO:

Please click the link below for full Prescribing Information:

If you have any questions regarding the information above, please contact us at info@reimbursementcodes.com or 1-860-563-1223.

Kind regards,

If you have received this notice in error, or would prefer not to receive further communications from this sender, please send an email to info@reimbursementcodes.com and detail your request. Include your name, organization name and email address.